CELEX: 62020TA0215
Language: en
Date: 2021-06-16 00:00:00
Title: Case T-215/20: Judgment of the General Court of 16 June 2021 — Fidia farmaceutici v EUIPO — Ioulia and Irene Tseti Pharmaceutical Laboratories (HYAL) (EU trade mark — Invalidity proceedings — EU word mark HYAL — Article 51(1)(a) of Regulation (EC) No 40/94 (now Article 59(1)(a) of Regulation (EU) 2017/1001) — Absolute ground for refusal — Article 7(1)(c) of Regulation No 40/94 (now Article 7(1)(c) of Regulation 2017/1001) — Right to be heard — Audi alteram partem rule — Obligation to state reasons — Sound administration and equal treatment — Article 165(1) of Regulation 2017/1001)

2.8.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 310/24
            
         
      Judgment of the General Court of 16 June 2021 — Fidia farmaceutici v EUIPO — Ioulia and Irene Tseti Pharmaceutical Laboratories (HYAL)
      (Case T-215/20) (1)
      
      (EU trade mark - Invalidity proceedings - EU word mark HYAL - Article 51(1)(a) of Regulation (EC) No 40/94 (now Article 59(1)(a) of Regulation (EU) 2017/1001) - Absolute ground for refusal - Article 7(1)(c) of Regulation No 40/94 (now Article 7(1)(c) of Regulation 2017/1001) - Right to be heard - Audi alteram partem rule - Obligation to state reasons - Sound administration and equal treatment - Article 165(1) of Regulation 2017/1001)
      (2021/C 310/30)
      Language of the case: English
      
         Parties
      
      
         Applicant: Fidia farmaceutici SpA (Abano Terme, Italy) (represented by: R. Kunz-Hallstein and H.P. Kunz-Hallstein, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented by: E. Sliwinska, V. Ruzek and H. O’Neill, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Ioulia and Irene Tseti Pharmaceutical Laboratories SA (Athens, Greece) (represented by: C. Chrysanthis, P.-V. Chardalia and A. Vasilogamvrou, lawyers)
      
         Re:
      
      Action brought against the decision of the Fifth Board of Appeal of EUIPO of 24 January 2020 (Case R 613/2019-5), relating to invalidity proceedings between Ioulia and Irene Tseti Pharmaceutical Laboratories and Fidia farmaceutici.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Fidia farmaceutici SpA to pay the costs.
               
            
         (1)  OJ C 201, 15.6.2020.